InvestorsHub Logo
Followers 91
Posts 4077
Boards Moderated 0
Alias Born 05/24/2011

Re: Je3232 post# 198155

Wednesday, 05/04/2016 2:14:19 PM

Wednesday, May 04, 2016 2:14:19 PM

Post# of 400880
You're so right, I mean a new board member with 40 years pharma experience isn't news at all....lolzzz What's his specialty? I'll help with the dd...

On April 28, 2016, our Board of Directors appointed Davis S. Caskey to the Board.

Davis Caskey brings more than 40 years of pharmaceutical industry experience to this position. From 1990 until 2013, Mr. Caskey was employed by ECR Pharmaceuticals (“ECR”), a venture that was founded in 1990 and was acquired by Hi-Tech Pharmacal Co., Inc. in March 2009, where he served as the operating officer. Upon leaving ECR, Mr. Caskey formed Caskey LLC, an umbrella company to provide consulting services to the pharmaceutical industry and for the management of other business interests. While at ECR, Mr. Caskey was credited with the establishment of ECR’s sales and marketing structure, its product distribution format, and management of the firm’s internal organization. His responsibilities included the oversight of drug development and regulatory filings. A primary focus was to conceive and develop, with the assistance of key strategic partners, extended release formulations of products which enhance patient compliance and safety. Prior to ECR, Mr. Caskey was employed by A.H. Robins for 18 years. His experience brings critical insight into the marketing and distribution of pharmaceutical products in a rapid and ever changing competitive marketplace. Mr. Caskey attended the University of Texas (Austin) and Lamar University, and holds bachelor’s and master’s degrees.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News